Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
AD Combes, CA Palma, R Calopedos, L Wen, H Woo… - Diagnostics, 2022 - mdpi.com
Prostate cancer is the most common cancer and the second leading cause of cancer death
in men. The imaging assessment and treatment of prostate cancer has vastly improved over …
in men. The imaging assessment and treatment of prostate cancer has vastly improved over …
Prognostic value of PSMA PET/CT in prostate cancer
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
Identification of the optimal candidates for nodal staging with extended pelvic lymph node dissection among prostate cancer patients who underwent preoperative …
Background Although the therapeutic role of extended pelvic lymph node dissection
(ePLND) in patients with prostate cancer (PCa) is still under debate, this procedure is …
(ePLND) in patients with prostate cancer (PCa) is still under debate, this procedure is …
The prognostic value of lymph node staging with prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and …
D Meijer, RH Ettema, PJ van Leeuwen… - BJU …, 2023 - Wiley Online Library
Objectives To investigate whether patients with suspected pelvic lymph node metastases
(molecular imaging [mi] N1) on staging prostate‐specific membrane antigen (PSMA) …
(molecular imaging [mi] N1) on staging prostate‐specific membrane antigen (PSMA) …
Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer
A Basso Dias, A Finelli, G Bauman, P Veit-Haibach… - Radiology, 2022 - pubs.rsna.org
Background Data regarding 2-(3-{1-carboxy-5-[(6-[18F] fluoro-pyridine 3-carbonyl)-amino]-
pentyl}-ureido)-pentanedioic acid (18F-DCFPyL) PET in primary staging of prostate cancer …
pentyl}-ureido)-pentanedioic acid (18F-DCFPyL) PET in primary staging of prostate cancer …
Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis …
S Lucciola, ML Pisciotti, M Frisenda… - Prostate Cancer and …, 2023 - nature.com
Abstract Background and objectives The Reporting and Data System (RADS) have been
used in the attempts to standardize the results of oncological scans in different scenarios …
used in the attempts to standardize the results of oncological scans in different scenarios …
[HTML][HTML] Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using …
Background Preoperative assessment of the probability of pelvic lymph-node metastatic
disease (pN1) is required to identify patients with prostate cancer (PCa) who are candidates …
disease (pN1) is required to identify patients with prostate cancer (PCa) who are candidates …
Current status and future perspective on the management of lymph node-positive prostate cancer after radical prostatectomy
M Shiota, L Blas, M Eto - Cancers, 2022 - mdpi.com
Simple Summary pN1 after RP with PLND represents one of the most unfavorable
prognostic factors for disease recurrence and cancer-specific mortality in prostate cancer …
prognostic factors for disease recurrence and cancer-specific mortality in prostate cancer …
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
Abstract Background [18F] PSMA-1007 is a promising tracer for integrated positron emission
tomography and computed tomography (PET/CT). Objective Our aim was to assess the …
tomography and computed tomography (PET/CT). Objective Our aim was to assess the …